Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failureElisabetta Degasperi, S. Fagiuoli, Angiola Spinetti et al.|Journal of Hepatology|2019Cited by 92
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphomaAlessandro Loglio, Pietro Lampertico, Mauro Viganò et al.|Digestive and Liver Disease|2018Cited by 16
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovirMauro Viganò, Pietro Lampertico, Alessandro Loglio et al.|Liver International|2018Cited by 10
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis BAlessandro Loglio, Pietro Lampertico, Massimo Iavarone et al.|Alimentary Pharmacology & Therapeutics|2018Cited by 7
P0655 : Lamivudine prophylaxis prevents hepatitis B reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non-Hodgkin's B cell lymphomaMauro Viganò, Pietro Lampertico, G. Grossi et al.|Journal of Hepatology|2015Cited by 4